Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Mallinckrodt
Johnson and Johnson
AstraZeneca

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

RUBIVITE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Rubivite patents expire, and what generic alternatives are available?

Rubivite is a drug marketed by Bel Mar and is included in one NDA.

The generic ingredient in RUBIVITE is cyanocobalamin. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

US ANDA Litigation and Generic Entry Outlook for Rubivite

A generic version of RUBIVITE was launched as cyanocobalamin by WEST-WARD PHARMS INT on December 12th, 2019.

Summary for RUBIVITE
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 28
Formulation / Manufacturing:see details
DailyMed Link:RUBIVITE at DailyMed
Drug patent expirations by year for RUBIVITE
Synonyms for RUBIVITE
0.1% Cobalamin Concentrate Trituration w/Mannitol
13408-78-1
14463-33-3
18534-66-2
5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
68-19-9
AB2000361
AKOS015894306
alpha-(5,6-dimethylbenzimidazolyl)cobamide
alpha-(5,6-Dimethylbenzimidazolyl)cyanocobamide
Anacobin
B12r
B12s
Bedoz
BEROCCA PN
Berubigen
C63H88CoN14O14P
CAS-68-19-9
CCG-220433
CHEBI:16304
CHEBI:28911
CHEBI:60488
cob(I)alamin
cob(I)alamin(1-)
Cob(II)alamin
Cob(III)alamin
cobalamin
Cobalamin (III)
Cobalamin;vitamin B-12;Cyanocobalamin
cobalamin(1+)
cobalamin(III)
Cobalamine
Cobavite
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Cobinamide,dihydrogenphosphate(ester),inner salt,3'-ester with(5,6-Dimethyl-1-a-d-ribofuranosyl-1H-benzimidazole-kn3),ion(1+)(9ci)
Cobolin-M
Crystamine
Crysti-12
Cyanocob(III)alamin
cyanocobalamin
CYANOCOBALAMIN 0.1% IN MANNITOL
Cyanocobalamin;Cyanocob(III)alamin
cyanoject
Cyomin
Depinar
Dicopac
DSSTox_CID_24346
DSSTox_GSID_44346
DSSTox_RID_80159
DTXSID7044346
H486
HMS1569G08
HMS2096G08
HMS3713G08
Hydroxomin
MolPort-016-633-264
Nascobal
NCGC00016302-01
NCGC00249888-01
Neuroforte-R
Prestwick_564
Primabalt
Redisol
Rubramin PC
Rubratope-57
Rubratope-60
RUBRATOPE-60 KIT
RUVITE
Shovite
Tox21_110358
Tox21_113664
V0344
Vi-Twel
Vibal
Vibisone
Vitabee 12
vitamin B-12r
vitamin B12
Vitamin B12 complex
Vitamin B12r
Vitamine B12

US Patents and Regulatory Information for RUBIVITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Medtronic
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.